-
C650260-5mgCinitapride is an orally active 5-HT 4 agonist and D 2 antagonist. Cinitapride shows gastroprotective properties on mucosal injury. Cinitapride can be used in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) research .In
-
C647390-1mgCinnarizine-d 8 is a deuterium labeled Cinnarizine. Cinnarizine is an antihistamine and a calcium channel blocker.Form:Solid.
-
C650424-10mgCipralisant (GT-2331) enantiomer is the enantiomer of Cipralisant ( HY-106993 ), Cipralisant is an orally active, potent, selective, and high affinity histamine H 3 receptor antagonist (rat K i =0.47 nM).Form:Solid.
-
C650424-1mgCipralisant (GT-2331) enantiomer is the enantiomer of Cipralisant ( HY-106993 ), Cipralisant is an orally active, potent, selective, and high affinity histamine H 3 receptor antagonist (rat K i =0.47 nM).Form:Solid.
-
C650424-5mgCipralisant (GT-2331) enantiomer is the enantiomer of Cipralisant ( HY-106993 ), Cipralisant is an orally active, potent, selective, and high affinity histamine H 3 receptor antagonist (rat K i =0.47 nM).Form:Solid.
-
C647445-10mgCipralisant (GT-2331) (maleate) is an orally active, low-toxicity, potent, selective, high affinity histamine H3 receptor full antagonist in vivo, and an agonist in vitro, with a pK i of 9.9 for histamine H3 receptor and a K i of 0.47 nM for rat
-
C647445-5mgCipralisant (GT-2331) (maleate) is an orally active, low-toxicity, potent, selective, high affinity histamine H3 receptor full antagonist in vivo, and an agonist in vitro, with a pK i of 9.9 for histamine H3 receptor and a K i of 0.47 nM for rat
-
C124102-100gCiprofibrate.
-
-
C124102-25gCiprofibrate.
-
C124102-500gCiprofibrate.
-